Dyadic International (NASDAQ: DYAI)
$1.50
(0.7%)
$0.01
Price as of April 24, 2024, 4:00 p.m. ET
Dyadic International Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Dyadic International Company Info
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.